Imperial College London


Faculty of MedicineSchool of Public Health

Clinical Fellow







Medical SchoolSt Mary's Campus




Selected Publications

Journal Articles

Nayagam AS, Chan P, Zhao K, et al., 2021, Investment case for a comprehensive package of interventions against Hepatitis B in China; applied modelling to help national strategy planning, Clinical Infectious Diseases, Vol:72, ISSN:1058-4838, Pages:743-752

Li X, Mukandavire C, Cucunuba ZM, et al., 2021, Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study, The Lancet, Vol:397, ISSN:0140-6736, Pages:398-408

Perez Guzman PN, Daunt A, Mukherjee S, et al., 2020, Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study, Clinical Infectious Diseases, Vol:2020, ISSN:1058-4838, Pages:1-11

Walker PGT, Whittaker C, Watson OJ, et al., 2020, The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries, Science, Vol:369, ISSN:0036-8075, Pages:413-422

Nayagam S, Shimakawa Y, Lemoine M, 2020, Mother-to-child transmission of hepatitis B: What more needs to be done to eliminate it around the world?, Journal of Viral Hepatitis, Vol:27, ISSN:1345-2533, Pages:342-349

Heffernan A, Cooke G, Nayagam S, et al., 2019, Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model, The Lancet, Vol:393, ISSN:0140-6736, Pages:1319-1329

Cooke GS, Andrieux-Meyer I, Applegate TL, et al., 2019, Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission, The Lancet Gastroenterology and Hepatology, Vol:4, ISSN:2468-1253, Pages:135-184

Hecht R, Hiebert L, Spearman WC, et al., 2018, The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up, Health Policy and Planning, Vol:33, ISSN:1460-2237, Pages:528-538

Nayagam S, Thursz M, Sicuri E, et al., 2016, Requirements for global elimination of hepatitis B: a modelling study, Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:1399-1408

Lemoine MN, Shimakawa Y, Njie R, et al., 2016, Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Global Health, Vol:4, ISSN:2214-109X, Pages:e559-e567

Nayagam S, Conteh L, Sicuri E, et al., 2016, Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis, Lancet Global Health, Vol:4, ISSN:2214-109X, Pages:e568-e578

More Publications